Filing Flows

Filing Flows › 8-K events › Harrow

Harrow: results of operations

Form 8-K filed Nov 9, 2026 · items 2.02, 7.01

Mergers and acquisitionsHarrow Announces Third Quarter 2026 Financial Results

What the filing says

• Record third quarter revenue of $99.3 million, up 41% sequentially and 39% year over year • Branded revenue of $83.5 million, up 62% year over year and approximately 84% of total revenue

ScaleThe filing names $99.3M: about 25% of Harrow's annual revenue ($397.2M, four times the latest quarter).

Read the filing on SEC EDGAR →

What usually followsAcross 69,249 8-Ks reporting Item 2.02 (results of operations) in our universe, the stock's median move the next session was +0.2% (typical size ±3.6%, up 51% of the time); over the following 21 sessions, +1.2%. Every item ranked →

Harrow at a glance

Latest quarterQ3 2026
Revenue$99.3M
Revenue Y/Y+39%
Operating margin11.6%
IndustryPharmaceutical Preparations

Harrow, Q3 2026: revenue $99.3M (+39% year over year), operating margin 11.6%. The chart follows the revenue to costs, profit and cash.

Harrow: every quarter, Q/Q and Y/Y, holders and guidance →

Other recent mergers and acquisitions

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.